

Pharmacovigilance (PV) Outsourcing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Pharmacovigilance (PV) Outsourcing market is expanding due to increasing regulatory demands and the need for efficient risk management. The market size is projected to reach approximately $7 billion by 2026, driven by advancements in technology and heightened focus on patient safety, enabling organizations to streamline operations and enhance compliance.
Request Sample Report
◍ Accenture
◍ C3i Solutions
◍ Clintec
◍ Covance
◍ Deloitte Touche Tohmatsu Limited
◍ ELC Group
◍ Ergomed
◍ iGATE Corporation
◍ iMED Global Corporation
◍ IQVIA
◍ MarksMan Healthcare
◍ Medpace Holdings
◍ Novartis
◍ Oracle Corporation
◍ Parexel
◍ PharmInvent
◍ PrimeVigilance
The Pharmacovigilance outsourcing market features key players like Accenture, IQVIA, and Parexel, leveraging technology and expertise to enhance drug safety and compliance. These companies provide reporting, analysis, and monitoring services, boosting operational efficiency and regulatory adherence. Notably, IQVIA reported revenues of approximately $13 billion in 2022.
◍ Pure Drug Safety
Request Sample Report
◍ Premarketing Clinical Trial
◍ Post-marketing Clinical Practice
◍ Other
◍ Contract Research Organizations (CROs)
◍ Business Process Outsourcing (BPOs)
Request Sample Report
Request Sample Report
$ X Billion USD